| Financial Year |
September 30 2020 |
| Monetary Funds |
1,031,434,594.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,914,931.34 |
| Accounts Receivable |
101,480,900.60 |
| Advances to Suppliers |
3,690,268.55 |
| Other Receivables |
1,007,031.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,445,894.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,702,657.44 |
| Total Current Assets |
1,156,676,278.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
25,000,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,251,416,449.34 |
| Under-construction Projects |
668,168,197.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,283,744.49 |
| R&D expenses |
-- |
| Goodwill |
21,216,657.22 |
| Long-Term Deferred and Prepaid Expenses |
2,955,186.61 |
| Deferred Income Tax Assets |
672,309.23 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,054,182,226.92 |
| Total Assets |
4,210,858,505.83 |
| Short-Term Loans |
545,770,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
108,696,068.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,763,764.31 |
| Taxes Payable |
9,677,265.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,512,534.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
444,003,479.28 |
| Other Current Liabilities |
3,362,436.01 |
| Sub-Total of Current Liabilities |
1,171,774,686.02 |
| Long-term Loans |
842,051,200.00 |
| Bonds Payable |
298,805,031.42 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
877,412.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,161,959,722.01 |
| Total Liabilities |
2,333,734,408.03 |
| Paid-In Capital(Or Share Stock) |
758,322,487.00 |
| Capital Surplus |
723,075,698.54 |
| Surplus Reserve |
103,281,055.79 |
| LESS:Treasury Stock |
1,750,000.00 |
| Undistributed Profits |
279,104,558.03 |
| Minority Stockholder's Interest |
15,090,298.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,862,033,799.36 |
| Owner's Equity（Stockholder's Equity） |
1,877,124,097.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,210,858,505.83 |
